| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1540 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1024 | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 817 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 603 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 444* | 2021 |
| Four phases of intravenous fluid therapy: a conceptual model EA Hoste, K Maitland, CS Brudney, R Mehta, JL Vincent, D Yates, ... British journal of anaesthesia 113 (5), 740-747, 2014 | 430 | 2014 |
| Impaired functional capacity is associated with all-cause mortality after major elective intra-abdominal surgery RJT Wilson, S Davies, D Yates, J Redman, M Stone British journal of anaesthesia 105 (3), 297-303, 2010 | 410 | 2010 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 233 | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 219 | 2022 |
| Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery DRA Yates, SJ Davies, HE Milner, RJT Wilson British journal of anaesthesia 112 (2), 281-289, 2014 | 217 | 2014 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 190 | 2021 |
| Prehabilitation J Durrand, R Hackett, D Yates, G Danjoux Perioperative Medicine–Current Controversies, 15-47, 2016 | 126 | 2016 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 86 | 2021 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 82 | 2023 |
| Randomized feasibility trial of high-intensity interval training before elective abdominal aortic aneurysm repair GA Tew, AM Batterham, K Colling, J Gray, K Kerr, E Kothmann, S Nawaz, ... Journal of British Surgery 104 (13), 1791-1801, 2017 | 54 | 2017 |
| Exploring patient attitudes to behaviour change before surgery to reduce peri‐operative risk: preferences for short‐vs. long‐term behaviour change S McDonald, D Yates, JW Durrand, E Kothmann, FF Sniehotta, ... Anaesthesia 74 (12), 1580-1588, 2019 | 50 | 2019 |
| Comparison of stroke volume and fluid responsiveness measurements in commonly used technologies for goal-directed therapy SJ Davies, S Minhas, RJT Wilson, D Yates, SJ Howell Journal of clinical anesthesia 25 (6), 466-474, 2013 | 49 | 2013 |
| Dopexamine has no additional benefit in high-risk patients receiving goal-directed fluid therapy undergoing major abdominal surgery SJ Davies, D Yates, RJT Wilson Anesthesia & Analgesia 112 (1), 130-138, 2011 | 40 | 2011 |
| Clinical risk assessment tools in anaesthesia J Stones, D Yates Bja Education 19 (2), 47, 2019 | 35 | 2019 |
